References
Fleckenstein A, Fleckenstein G, Frey M,et al. Future directions in the use of calcium antagonists.Am J Cardiol 1987; 59:117B-187B.
Nayler WG. Calcium antagonists and the ischemic myocardium.Int J Cardiol 1987; 15:267–285.
Gibson RS, Boden WE, Theroux P,et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction.N Engl J Med 1986; 315:423–429.
Muller JE, Morrison HJ, Stone PH,et al. Nifedipine therapy for patients with threatened and acute myocardial infarction: A randomized, double-blind, placebo-controlled comparison.Circulation 1984; 69:740–747.
Danish Multicenter Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction.Am J Cardiol 1984; 54:24E-38E.
Danish Study Group on verapamil and myocardial infarction. The Danish studies on verapamil in acute myocardial infarction.Br J Clin Pharmacol 1986; 21(Suppl 2):197S-204S.
Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade.Pharmacol Rev 1986; 38:321–416.
Nayler WG, Dillon JS, Elz JS, et al. An effect of ischemia on myocardial dihydropyridine binding sites.Eur J Pharmacol 1985; 81–89.
Gu XH, Dillon JS, Nayler WG. Effect of temperature and time on 1,4 dihydropyridine binding sites on membrane fragments from ischemic and reperfused rat hearts.J Cardiovasc Pharm (in press).
Zanchetti A. The role of calcium antagonists in systemic hypertension.Am J Cardiol 1986; 59(Suppl 3):130B-136B.
Garthoff B, Hirth C, Federmann A,et al. Renal effects of 1,4-dihydropyridines in animal models of hypertension and renal failure.J Cardiovasc Pharmacol 1987; 9(Suppl 1):S8-S13.
Henry PD. Atherosclerosis, calcium and calcium antagonists.Circulation 1985; 72:456–459.
Saito Y, Fujiyama Y, Shirai K,et al. Effect of nifedipine on lipid metabolism in smooth muscle cells. In Lichtlen PR, (ed): Proceedings Sixth International Adalat Symposium.Br Excerp Med 1986; 480–483.
Mehta J, Mehta P, Ostrowski N,et al. Effects of verapamil on platelet aggregation, ATP release and thromboxane generation.Thromb Res 1983; 30:469–474.
Nayler WG, Panagiotopoulos S, Elz JS,et al. Fundamental mechanisms of action of calcium antagonists in myocardial ischaemia.Am J Cardiol 1987; 59:75B-83B.
Irita K, Fujita I, Koichiro T,et al. Calcium channel antagonist-induced inhibition of superoxide production in human neutrophils.Biochem Pharmacol 1986; 35:3465–3471.
Yalowich JC, Ross WE. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.Cancer Res 1984; 44:3360–3365.
Bongianni F, Carla V, Moroni F,et al. Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.Br J Pharmacol 1986; 88:561–567.
Little HJ, Dolin SJ, Halsey MJ. Calcium channel antagonists decrease the ethanol withdrawal syndrome.Life Sci 1986; 39:2059–2065.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nayler, W.G. Calcium antagonists: Whither now?. Cardiovasc Drug Ther 1, 617–619 (1988). https://doi.org/10.1007/BF02125748
Issue Date:
DOI: https://doi.org/10.1007/BF02125748